0001209191-21-039091.txt : 20210609
0001209191-21-039091.hdr.sgml : 20210609
20210609103658
ACCESSION NUMBER: 0001209191-21-039091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210608
FILED AS OF DATE: 20210609
DATE AS OF CHANGE: 20210609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashiya Mona
CENTRAL INDEX KEY: 0001794070
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37490
FILM NUMBER: 211004361
MAIL ADDRESS:
STREET 1: C/O SIERRA ONCOLOGY, INC.
STREET 2: 2150 - 885 WEST GEORGIA STREET
CITY: VANCOUVER, BRITISH COLUMBIA
STATE: Z4
ZIP: V6C 3E8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sierra Oncology, Inc.
CENTRAL INDEX KEY: 0001290149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
BUSINESS PHONE: 604-558-6536
MAIL ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
FORMER COMPANY:
FORMER CONFORMED NAME: ProNAi Therapeutics Inc
DATE OF NAME CHANGE: 20040513
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-08
0
0001290149
Sierra Oncology, Inc.
SRRA
0001794070
Ashiya Mona
C/O SIERRA ONCOLOGY, INC.
1820 GATEWAY DRIVE, SUITE 110
SAN MATEO
CA
94404
1
0
1
0
Stock Option (Right To Buy)
18.11
2021-06-08
4
A
0
6000
0.00
A
2031-06-08
Common Stock
6000
6000
D
The Option fully vests and becomes exercisable on June 8, 2022, subject to the Reporting Person's provision of service to the Issuer as of the vesting date.
Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VII, LP.
/s/ Mona Ashiya; By: Mary Christina Thomson, Attorney-In-Fact
2021-06-09